Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Niaspan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE High-mobility group box 1 (HMGB1), an active receptor for advanced glycation endproducts (RAGE), functions as a potent… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
We investigated the changes and the molecular mechanisms of cerebral vascular damage and tested the therapeutic effects of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
OBJECTIVE High-density lipoprotein (HDL) is implicated in the modulation of angiogenesis. In this study, we investigated whether… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Diabetic dyslipidemia is characterized by high triglyceride levels; low high-density lipoprotein cholesterol levels… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2001
2001
Niaspan, when added to a stable dose of a statin in 66 subjects, was found to be safe and highly effective in improving lipid… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To provide a direct comparison of agents that raise plasma levels of high-density lipoprotein cholesterol (HDL-C) to… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Crystalline nicotinic acid (immediate-release niacin) is effective therapy for lipoprotein regulation and cardiovascular risk… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
This study compared the efficacy and safety of a once-a-night, time-release niacin formulation, Niaspan (Kos Pharmaceuticals… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Niacin is a useful lipid-modifying drug because it (1) decreases low-density lipoprotein (LDL) cholesterol, total cholesterol… Expand
Is this relevant?
1996
1996
BACKGROUND: The present study was designed to determine the efficacy and safety of Niaspan (Kos Pharmaceuticals, Inc, Hollywood… Expand
Is this relevant?